ARS
AZN icon

Adirondack Retirement Specialists’s AstraZeneca AZN Stock Holding History

Adirondack Retirement Specialists’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5
Closed -$716 – 36
2023
Q2 		$716 Hold
5
– – ﹤0.01% 121
2023
Q1 		$703 Hold
5
– – ﹤0.01% 134
2022
Q4 		$678 Hold
5
– – ﹤0.01% 110
2022
Q3 		$1K Buy
+5
New +$634 ﹤0.01% 101

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Adirondack Retirement Specialists's AZN Position: Q3 2023 in Review

Adirondack Retirement Specialists sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 5 shares — an estimated $716 sold.

Adirondack Retirement Specialists first reported a position in AZN in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 1,073 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

  • Adirondack Retirement Specialists reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
  • Adirondack Retirement Specialists sold 5 AstraZeneca shares in Q3 2023, an estimated $716.
  • Adirondack Retirement Specialists first reported a position in AstraZeneca in Q3 2022 and held it in 4 quarters.
  • Adirondack Retirement Specialists's AstraZeneca position peaked at $1K in Q3 2022.
  • 1,073 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Adirondack Retirement Specialists's 13F filing for Q3 2023, filed 24 Oct 2023.